Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

Clinical trial NCT00661544 · COMPLETED

Trial details

NCT number: NCT00661544
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Stem Cell Transplantation

Start date: 2004-03-01
Primary completion: 2007-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.